Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1636]

Researchers reveal why some pancreatic tumours behave differently

Researchers reveal why some pancreatic tumours behave differently

Reversing immune suppression in pancreatic cancer could lead to novel therapies

Reversing immune suppression in pancreatic cancer could lead to novel therapies

Less survivable cancers receive just 19% of research funding despite causing 40% of all cancer deaths in the UK

Less survivable cancers receive just 19% of research funding despite causing 40% of all cancer deaths in the UK

Potential tumour-suppressing gene identified in pancreatic cancer

Potential tumour-suppressing gene identified in pancreatic cancer

LLM treatment advice agrees with physician recommendations in early-stage HCC, but falls short in late stage

LLM treatment advice agrees with physician recommendations in early-stage HCC, but falls short in late stage

Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer

Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer

Whole-genome sequencing may optimise PARP inhibitor use

Whole-genome sequencing may optimise PARP inhibitor use

Short-circuiting pancreatic cancer

Short-circuiting pancreatic cancer

ASCO GI 2026: Long-term study suggests walking is key to managing cancer-related fatigue

ASCO GI 2026: Long-term study suggests walking is key to managing cancer-related fatigue

Promising target improves antitumour response in preclinical models of pancreatic cancer

Promising target improves antitumour response in preclinical models of pancreatic cancer

More from ecancer